| (Values in U.S. Thousands) | Jul, 2025 | Jul, 2024 | Jul, 2023 | Jul, 2022 | Jul, 2021 |
| Sales | 165 | 147 | 161 | 28,824 | 24,359 |
| Sales Growth | +12.20% | -8.51% | -99.44% | +18.33% | +6.41% |
| Net Income | -8,049 | -6,908 | 16,138 | -4,562 | 562 |
| Net Income Growth | -16.52% | -142.81% | +453.73% | -912.52% | +113.03% |
Kda Group Inc (KDA.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
KDA Group Inc provides solutions and services to the Canadian pharmaceutical market. The company's operating segments include Pharmacy Services; Pharmaceutical Solutions and Technology. It generates maximum revenue from the Pharmacy Services segment.
Fiscal Year End Date: 07/31